<DOC>
	<DOCNO>NCT00768183</DOCNO>
	<brief_summary>The objective study compare single-dose relative bioavailability Alpharma Branded Products Division Inc. ( KADIAN ) 100 mg morphine sulfate extended-release capsule dose alcohol fast feed condition compare water . In addition , pharmacokinetics immediate release solution follow 20 mg dose assess informational purpose possible modeling .</brief_summary>
	<brief_title>Comparison KADIAN 100 mg When Dosed With Alcohol Under Fasting Fed Conditions Compared Water</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>Healthy adult male volunteer , 21 40 year age . Subjects nonsmoker least 3 month light smoker ( less 10 packyears ) . Subjects history moderate consumption least 721 unit alcohol per week alcohol equivalent ( 12 oz beer = 5 oz 80proof distilled spirit = 1 unit ) . Weighing least 70 kg within 20 % ideal weight ( table `` Desirable Weights Adults '' , Metropolitan Life Insurance Company , 1983 ) . Medically healthy subject clinically significant abnormality laboratory profile ECGs , deem Principal Investigator . Voluntarily consent participate study . History presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease . In addition , history presence : alcoholism drug abuse ; asthma chronic respiratory illness ; diabetes ; gastrointestinal dysmotility , irritable bowel syndrome , chronic constipation recent enteritis ; hypersensitivity idiosyncratic reaction morphine opioids ; hypersensitivity idiosyncratic reaction naltrexone , naloxone , opioids antagonist . History alcohol intake ( alcoholnaive ) less moderate alcohol intake . Subject history alcohol intake exceed equivalence 21 units/week exceed average 3 drink per day . Subjects surgery gastrointestinal tract ( except appendectomy ) would interfere absorption study drug . Subjects receive hepatic enzyme induce drug ( e.g . Nizoral , Tagamet ) within previous three month . Subjects whose QTc interval &gt; 450 msec screen prior dosing . Subjects whose sit blood pressure le 110/45 mm Hg screen 100/45 mm Hg dosing . Subjects special diet ( whatever reason ) 28 day prior first dose throughout study . Subjects make significant donation loss blood within 56 day . Subjects make plasma donation within 7 day prior study . Subjects hemoglobin less 12.0 g/dL . Subjects participate another clinical trial within 28 day prior first dose . Subjects positive urine test drug abuse alcohol . Subjects positive test , treat hepatitis B , hepatitis C HIV .</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>KADIAN</keyword>
	<keyword>morphine</keyword>
	<keyword>alcohol</keyword>
	<keyword>water</keyword>
	<keyword>Ethanol</keyword>
	<keyword>solution</keyword>
	<keyword>fed</keyword>
	<keyword>fast</keyword>
</DOC>